CMS quietly ended a pay-for-performance plan for Novartis' Kymriah—a half-million-dollar cancer treatment; President Donald Trump’s nomination of Judge Brett M. Kavanaugh to the Supreme Court sets up an intense partisan fight over health care; lawmakers in Maine's state House failed to override Republican Governor Paul LePage's veto of a bill that would fund the first year of Medicaid expansion.
CMS quietly killed a pay-for-performance plan for a chimeric antigen receptor (CAR) T-cell therapy—Novartis' Kymriah, which is a half-million-dollar cancer treatment, Politico reported. The deal drew internal HHS scrutiny and is the target of current congressional investigations. CMS refused to comment on the story, but Politico said emails showed that administration lawyers were uncomfortable with how much Novartis was influencing the arrangement, including counseling CMS on the payment criteria for the breakthrough drug.
President Donald Trump’s nomination of Judge Brett M. Kavanaugh to the Supreme Court sets up an intense partisan fight over reproductive health care and possibly the Affordable Care Act (ACA). NPR reported that abortion and the ACA are top of mind for a large number of Senate Democrats in their fight to persuade moderate Republicans and moderates in their own party to oppose Kavanaugh. Senate Majority Leader Mitch McConnell, R-Kentucky, leads the slimmest of majorities and had expressed misgivings about Kavanaugh's path to confirmation, but said he was a “superb choice.”
Lawmakers in Maine's state House failed to override Republican Governor Paul LePage's veto of a bill that would fund the first year of Medicaid expansion, The Hill reported. The 85-58 vote of the $60 million bill fell short of the two-thirds majority needed to pass. Maine voters approved Medicaid expansion last year, but LePage has blocked its implementation. His administration has asked the Maine Supreme Judicial Court to delay the expansion until the state legislature passes a bill funding its share of the costs.
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Study Links COVID-19 Pandemic to Rise in Neoadjuvant Chemotherapy for Ovarian Cancer in US
April 17th 2024There was greater use of neoadjuvant chemotherapy among US patients with ovarian cancer (OC) during the COVID-19 pandemic to reduce potential COVID-19 exposure and cancer treatment-related complications.
Read More
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More